The partnership is part of BioNTech’s strategy to develop novel prophylactic vaccines for the prevention of high-medical-need infectious diseases
DKSH has further fortified its strategic partnership with Biolin Scientific, a globally recognized pioneer in surface science instrumentation, across nine key markets in the APAC region
This transformation will enable GE HealthCare to build a strong foundation for business growth
Both the companies intend to facilitate faster clinical trial enrollment and provide patients with access to novel medications
The partnership will commercialize four nasal sprays with a combined Global IQVIA market size in excess of $400m
The milestone of operating continuously a very complex system for over two years has demonstrated the effectiveness of integrated laboratory automation solutions
Patients will no longer need to travel abroad for treatment of acute cardiac diseases
The strategic acquirer maintains a nationwide presence in the LTC pharmacy space
As per the agreement, NSE-listed Vaishali Pharma Limited will take over the entire domestic and international marketing of Jark Pharma’s portfolio of quality based ayurvedic products
Empagliflozin is a novel sodium glucose co-transporter-2 (SGLT-2) inhibitor, which is useful for improving glycaemic control in adults with type-2 diabetes mellitus.
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
